About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Dermatology
›
top-articles
Department of Dermatology
162
(top 1%)
papers
4.2K
(top 1%)
citations
38
(top 1%)
h
-index
57
(top 1%)
g
-index
168
all documents
4.5K
doc citations
1.3K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
Journal of the American Academy of Dermatology
2020
224
2
Symptom profile and risk factors of anaphylaxis in Central Europe
Allergy: European Journal of Allergy and Clinical Immunology
2012
149
3
Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model
PLoS ONE
2015
149
4
Provoking allergens and treatment of anaphylaxis in children and adolescents – data from the anaphylaxis registry of German‐speaking countries
Pediatric Allergy and Immunology
2011
137
5
Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
Journal of the American Academy of Dermatology
2015
133
6
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
Nature Communications
2017
109
7
UME6
is a crucial downstream target of other transcriptional regulators of true hyphal development in
Candida albicans
FEMS Yeast Research
2009
104
8
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines
British Journal of Dermatology
2016
102
9
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
Science Translational Medicine
2018
91
10
Functional Correction of Type VII Collagen Expression in Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
2011
78
11
Age‐related changes in the composition of the cornified envelope in human skin
Experimental Dermatology
2013
78
12
Murgocil is a Highly Bioactive Staphylococcal-Specific Inhibitor of the Peptidoglycan Glycosyltransferase Enzyme MurG
ACS Chemical Biology
2013
75
13
Mitochondrial dysfunction: a neglected component of skin diseases
Experimental Dermatology
2014
71
14
Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
2017
70
15
Spliceosome-Mediated Trans-Splicing: The Therapeutic Cut and Paste
Journal of Investigative Dermatology
2012
67
16
Allergen Chip Diagnosis for Soy-Allergic Patients: Gly m 4 as a Marker for Severe Food-Allergic Reactions to Soy
International Archives of Allergy and Immunology
2013
64
17
Herlitz Junctional Epidermolysis Bullosa
Dermatologic Clinics
2010
63
18
The galanin peptide family in inflammation
Neuropeptides
2011
63
19
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis
Cancer Immunology, Immunotherapy
2016
62
20
International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita
British Journal of Dermatology
2018
62
21
Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients
American Journal of Clinical Dermatology
2020
60
22
Dendritic Cells Activated by IFN-γ/STAT1 Express IL-31 Receptor and Release Proinflammatory Mediators upon IL-31 Treatment
Journal of Immunology
2012
57
23
Seborrheic keratosis: Reflectance confocal microscopy features and correlation with dermoscopy
Journal of the American Academy of Dermatology
2013
57
24
GAL
3
receptor
KO mice exhibit an anxiety-like phenotype
Proceedings of the National Academy of Sciences of the United States of America
2014
57
25
K14 mRNA reprogramming for dominant epidermolysis bullosa simplex
Human Molecular Genetics
2010
55
26
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
2020
55
27
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
ESMO Open
2016
54
28
Clinical Effectiveness of Hymenoptera Venom Immunotherapy: A Prospective Observational Multicenter Study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity
PLoS ONE
2013
52
29
Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses
Particle and Fibre Toxicology
2015
52
30
Novel KIND1 Gene Mutation in Kindler Syndrome With Severe Gastrointestinal Tract Involvement
Archives of Dermatology
2006
49
31
Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study
Orphanet Journal of Rare Diseases
2013
48
32
Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial
Journal of the American Academy of Dermatology
2018
48
33
Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging
Aging
2015
44
34
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
European Journal of Cancer
2019
44
35
Mitochondrial Haplogroups, Control Region Polymorphisms and Malignant Melanoma: A Study in Middle European Caucasians
PLoS ONE
2011
43
36
Cross‐sectional study on allergic sensitization of Austrian adolescents using molecule‐based IgE profiling
Allergy: European Journal of Allergy and Clinical Immunology
2017
42
37
The Pathogenetic Role of IL-1β in Severe Epidermolysis Bullosa Simplex
Journal of Investigative Dermatology
2013
41
38
Multi-Modal Treatment Of Calciphylaxis With Sodium-Thiosulfate, Cinacalcet And Sevelamer Including Long-Term Data
Kidney and Blood Pressure Research
2013
41
39
Evaluation of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides
JAMA Dermatology
2019
41
40
Direct and Indirect Immunofluorescence for the Diagnosis of Bullous Autoimmune Diseases
Dermatologic Clinics
2011
40
41
Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry
Journal of Allergy and Clinical Immunology
2021
40
42
Immunofluorescence Mapping for the Diagnosis of Epidermolysis Bullosa
Dermatologic Clinics
2010
38
43
Lesion-Induced Accumulation of Platelets Promotes Survival of Adult Neural Stem / Progenitor Cells
Experimental Neurology
2015
33
44
Epidermolysis Bullosa Nevi
Dermatologic Clinics
2010
32
45
TGFβ-signaling in Squamous Cell Carcinoma Occurring in Recessive Dystrophic Epidermolysis Bullosa
Analytical Cellular Pathology
2011
31
46
Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient
Lung Cancer
2016
31
47
Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations
Gene Therapy
2016
31
48
Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy
Journal of Controlled Release
2017
31
49
Extended surgical safety margins and ulceration are associated with an improved prognosis in pleomorphic dermal sarcomas
Journal of the European Academy of Dermatology and Venereology
2019
31
50
Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade
Leukemia
2014
29
site/software ©
exaly
; All materials licenced under
CC by-SA
.